Depression and anxiety disorders

被引:27
作者
Brown, CS
机构
[1] Univ Tennessee, Ctr Hlth Sci, Dept Pharm Practice & Pharmacoecon, Memphis, TN 38163 USA
[2] Univ Tennessee, Ctr Hlth Sci, Dept Obstet & Gynecol, Memphis, TN 38163 USA
[3] Univ Tennessee, Ctr Hlth Sci, Dept Psychiat, Memphis, TN 38163 USA
关键词
D O I
10.1016/S0889-8545(05)70199-6
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Because of a greater prevalence of depressive and anxiety disorders among women, a substantial part of an obstetrician gynecologist's practice is concerned with the management of these disorders. This article depicts how women with these disorders present to a primary care clinic and how the menstrual cycle, pregnancy and lactation may affect symptoms. General principles of management are discussed, including suicide assessment, medical evaluation, psychotherapy, pharmacologic treatment, and psychiatric referral. The selective serotonergic reuptake inhibitors (SSRIs) are described as first-line treatment for most depressive and anxiety disorders because of the overall efficacy and favorable side effect profile. Other pharmacologic agents are discussed for women who are unresponsive to or intolerant of the SSRIs. Although psychotherapy is preferred to antidepressants during pregnancy and lactation, guidelines for appropriate antidepressant use are provided.
引用
收藏
页码:241 / +
页数:29
相关论文
共 104 条
[1]  
ALSHULTER LL, 1998, TXB WOMENS HTLH, P809
[2]  
Altshuler LL, 1996, AM J PSYCHIAT, V153, P592
[3]  
Altshuler LL, 1998, J CLIN PSYCHIAT, V59, P29
[4]  
*AM PHARM ASS, 1999, DRUG TREATM PROT, P299
[5]  
Amer Psychiat Assoc, 1998, AM J PSYCHIAT, V155, P1
[6]  
[Anonymous], 1993, AM J PSYCHIAT, V150, P1
[7]   PERSISTENCE OF SYMPTOMS OF PREMENSTRUAL TENSION IN HYSTERECTOMIZED WOMEN [J].
BACKSTROM, CT ;
BOYLE, H ;
BAIRD, DT .
BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1981, 88 (05) :530-536
[8]  
BALLENGER JC, 2000, J CLIN PSYCHIAT S5, V61, P50
[9]  
BARRETT JE, 1988, ARCH GEN PSYCHIAT, V45, P1100
[10]  
Bhatia SC, 1999, AM FAM PHYSICIAN, V60, P225